Mostrar el registro sencillo del ítem

Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility

dc.contributor.authorKachuri, L.
dc.contributor.authorJohansson, M.
dc.contributor.authorRashkin, S. R.
dc.contributor.authorTardón García, Adonina 
dc.date.accessioned2020-06-26T07:57:08Z
dc.date.available2020-06-26T07:57:08Z
dc.date.issued2020
dc.identifier.citationNature Communications, 11(1), p. 27- (2020); doi:10.1038/s41467-019-13855-2
dc.identifier.issn2041-1723
dc.identifier.urihttp://hdl.handle.net/10651/55251
dc.description.sponsorshipThis research was supported by funding from the National Institutes of Health (US NCI R25T CA112355 and R01 CA201358; PI: Witte) and the Canadian Institute for Health Research (Foundation grant FDN 167273, PI: Hung; Canada Research Chair, PI: Hung). The OncoArray project was supported by NIH U19 CA203654 (MPI: Hung, Amos, Brennan, Lin). The Boston Lung Cancer Study was funded by NIH (NCI) U01CA209414 (PI: Christiani). The lung eQTL study at Laval University was supported by the Fondation de l’Institut universitaire de cardiologie et de pneumologie de Québec and the Canadian Institutes of Health Research (MOP − 123369). Y.B. holds a Canada Research Chair in Genomics of Heart and Lung Diseases. The EAGLE study was supported by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS. The Multiethnic Cohort Study is supported by National Institutes of Health (CA164973). The CARET study was supported by the National Institutes of Health/National Cancer Institute: UM1 CA167462 (PI: Goodman), U01 CA6367307 (PIs: Omen, Goodman); R01 CA111703 (PI: Chen), 5R01 CA151989-01A1 (PI: Doherty) and U01 CA167462 (PI: Chen). M.B.S. was supported in part by a Cancer Center Support Grant (P30 CA076292) and by NIH P50 CA119997. R.M.M. is supported by a CRUK programme grant, the Integrative Cancer Epidemiology Programme (C18281/A19169), and by the National Institute for Health Research (NIHR) Bristol Biomedical Research Centre based at University Hospitals Bristol NHS Foundation Trust and the University of Bristol.
dc.description.statementofresponsibilityKachuri, L., Johansson, M., Rashkin, S.R., Graff, R.E., Bossé, Y., Manem, V., Caporaso, N.E., Landi, M.T., Christiani, D.C., Vineis, P., Liu, G., Scelo, G., Zaridze, D., Shete, S.S., Albanes, D., Aldrich, M.C., Tardón, A., Rennert, G., Chen, C., Goodman, G.E., Doherty, J.A., Bickeböller, H., Field, J.K., Davies, M.P., Dawn Teare, M., Kiemeney, L.A., Bojesen, S.E., Haugen, A., Zienolddiny, S., Lam, S., Le Marchand, L., Cheng, I., Schabath, M.B., Duell, E.J., Andrew, A.S., Manjer, J., Lazarus, P., Arnold, S., McKay, J.D., Emami, N.C., Warkentin, M.T., Brhane, Y., Obeidat, M., Martin, R.M., Relton, C., Davey Smith, G., Haycock, P.C., Amos, C.I., Brennan, P., Witte, J.S., Hung, R.J.
dc.format.extentp. 27-
dc.language.isoeng
dc.relation.ispartofNature Communications, 11
dc.rights© 2020 Kachuri et al.
dc.rightsCC Reconocimiento 4.0 Internacional 4.0
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85077517966&doi=10.1038%2fs41467-019-13855-2&partnerID=40&md5=efef7a08298e9f37ef3dbf2b6ee225d7
dc.titleImmune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
dc.typejournal article
dc.identifier.doi10.1038/s41467-019-13855-2
dc.relation.publisherversionhttp://dx.doi.org/10.1038/s41467-019-13855-2
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2020 Kachuri et al.
Este ítem está sujeto a una licencia Creative Commons